Related references
Note: Only part of the references are listed.Glycopyrrolate for sialorrhea in Parkinson disease A randomized, double-blind, crossover trial
M. E. L. Arbouw et al.
NEUROLOGY (2010)
RANDOMIZED DOUBLE-BLIND STUDY OF BOTULINUM TOXIN TYPE B FOR SIALORRHEA IN ALS PATIENTS
Carlayne E. Jackson et al.
MUSCLE & NERVE (2009)
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology
R. G. Miller et al.
NEUROLOGY (2009)
Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence-based review with good practice points. EALSC Working Group
Peter Munch Andersen et al.
AMYOTROPHIC LATERAL SCLEROSIS (2007)
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis
SC Bourke et al.
LANCET NEUROLOGY (2006)
Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease
O Dogu et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2004)
Nebulized glycopyrrolate for drooling in a motor neuron patient
R Strutt et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Share Paper
